CTVENPOSTPART: Computed Tomography CT Venography During Postpartum Venous Thromboembolism

Sponsor
Assistance Publique - Hôpitaux de Paris (Other)
Overall Status
Completed
CT.gov ID
NCT02616991
Collaborator
(none)
125
1
1
57.9
2.2

Study Details

Study Description

Brief Summary

The purpose of this study is to determine whether systematically performing computed tomography (CT) venography (i.e a CT acquisition of the pelvis and of the lower limbs, during the venous phase of opacification) in addition to thoracic CT angiography in women with suspected postpartum pulmonary embolism (PE) results in a gain in venous thromboembolism detection rate.

Condition or Disease Intervention/Treatment Phase
  • Procedure: computed tomography venography
N/A

Detailed Description

Pulmonary embolism (PE) remains a leading cause of maternal death during postpartum in developed countries; Thoracic computed tomography angiography (CTA) is the first-line diagnostic test for PE suspicion, but has a 20 to 35% rate of inconclusiveness during pregnancy and postpartum, 2 to 3 times higher than that of the general population. CT venography (CTV) consists in a delayed CT acquisition of the abdomen, pelvis and lower limbs, 3 minutes after starting contrast administration. It can be used for detecting deep venous thrombosis (DVT), the source of emboli in most PEs. The investigators hypothesized most postpartum PEs are due to pelvic vein thrombosis and that detecting such pelvic DVT by performing systematic CTV could increase the overall venous thromboembolism (VTE) detection.

Study Design

Study Type:
Interventional
Actual Enrollment :
125 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Contribution of CT Venography for Diagnosing Venous Thromboembolism During Postpartum
Actual Study Start Date :
Jun 4, 2016
Actual Primary Completion Date :
Dec 4, 2020
Actual Study Completion Date :
Apr 2, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Cohort

computed tomography venography

Procedure: computed tomography venography
systematically performing computed tomography venography in addition to thoracic computed tomography angiography

Outcome Measures

Primary Outcome Measures

  1. Number of detected venous thromboembolism (VTE) based on Computed Tomography Angiography (CTA) plus Computed Tomography Venography (CTV) [one day]

    VTE detection rate for readings based on CTA plus CTV as compared to readings based on CTA alone

Secondary Outcome Measures

  1. Radiation doses due to CT venography [3 months]

  2. kappa coefficients assessing inter-readers agreement for CT venography readings [3 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Women with clinically suspected pulmonary embolism (PE) during the first 6 weeks postpartum, without any sign of severe PE (shock, hypotension), referred for CT angiography

  • Absence of contraindication to iodinated contrast medium injection (Previous allergic reaction to iodinated contrast medium, renal insufficiency with creatine clearance less than 30mL/mn, uncontrolled hyperthyroidism)

  • Age > 18 years

  • Health insurance

  • Possibility to have 3-month follow-up

  • Obtention of written informed consent (ability to give consent)

Exclusion Criteria:
  • Anticoagulation at therapeutic dosage for another reason than the suspicion of PE for more than 72 hours

  • New pregnancy (In case of any doubt after medical history review, βHCG blood test must be realized to ensure patient's pregnancy status)

  • Contrast medium extravasation during injection

  • CTA or CTV not performed according to the study requirements

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cochin Hospital Paris France 75014

Sponsors and Collaborators

  • Assistance Publique - Hôpitaux de Paris

Investigators

  • Principal Investigator: Marie-Pierre REVEL, MD, PhD, Assistance Publique - Hôpitaux de Paris
  • Study Chair: Guy MEYER, PhD, University of Paris 5 - Rene Descartes

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier:
NCT02616991
Other Study ID Numbers:
  • 2015-002741-64
  • 2015-A01262-47
First Posted:
Nov 30, 2015
Last Update Posted:
May 4, 2021
Last Verified:
Apr 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 4, 2021